YOSHIO YAMAOKA to Proton Pump Inhibitors
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Proton Pump Inhibitors.
Connection Strength
3.396
-
CYP2C19 genotype-guided dosing of proton pump inhibitors: progress in clinical trials and real-world use. Expert Rev Clin Pharmacol. 2026 Jan-Feb; 19(2):133-150.
Score: 0.776
-
Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for Helicobacter pylori eradication: a systematic review and network meta-analysis. BMJ Open Gastroenterol. 2026 Jan 14; 13(1).
Score: 0.772
-
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules. 2015 Apr 08; 20(4):6068-92.
Score: 0.366
-
Strategy for the treatment of Helicobacter pylori infection. Curr Pharm Des. 2014; 20(28):4489-500.
Score: 0.335
-
Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009 Nov; 24(11):1725-32.
Score: 0.251
-
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs. 2008; 68(6):725-36.
Score: 0.221
-
Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam. Gut Liver. 2019 09 15; 13(5):483-497.
Score: 0.124
-
An East-Asian-type cagA Helicobacter pylori Infected Patient with Clinical Manifestation of Gastric Ulcer. Acta Med Indones. 2016 Oct; 48(4):307-313.
Score: 0.101
-
Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013 Jan; 7(1):35-40.
Score: 0.078
-
Association of helicobacter pylori dupA with the failure of primary eradication. J Clin Gastroenterol. 2012 Apr; 46(4):297-301.
Score: 0.074
-
Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial). Sci Rep. 2025 Dec 18; 15(1):44105.
Score: 0.048
-
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005 Nov; 100(11):2387-92.
Score: 0.048
-
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori-Infected Peptic Ulcer Children in Vietnam. Helicobacter. 2024 Nov-Dec; 29(6):e13149.
Score: 0.044
-
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. Am J Gastroenterol. 2023 07 01; 118(7):1184-1195.
Score: 0.040
-
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003 Jan; 17(2):193-200.
Score: 0.039
-
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
Score: 0.033
-
Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
Score: 0.028
-
Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003 May; 98(5):1005-9.
Score: 0.010
-
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy. J Gastroenterol Hepatol. 1998 Jul; 13(7):732-7.
Score: 0.007